Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02520050 · ClinicalTrials.gov registry record · NA
The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM
A NA study, sponsored by Joslin Diabetes Center.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
NCT02520050 is a NA study that has completed, run by Joslin Diabetes Center. The registered enrollment target is 108 participants.
The verdict
NCT02520050, a NA study, has completed, sponsored by Joslin Diabetes Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
Study Summary
The American Diabetes Association (ADA), among other medical societies, is strongly recommending medical nutrition therapy (MNT) for prevention and management of type 2 diabetes. However, the ADA recognized that there is no "one size fits all" diet and thus recommends that MNT should be conducted through a consultation with registered dietitians (RD). Previous studies have shown that using diabetes-specific nutritional formulas, as an integral part of the MNT, lowers postprandial blood glucose levels. Through our experience from the Joslin's Weight Achievement and Intensive Treatment (Why WAIT™) program, applying MNT within a structured dietary intervention protocol has the best impact on blood glucose values and body weight. Meanwhile, the frequent use of health coaching during dietary intervention proved to be effective in managing diabetes and inducing weight loss. However, no study compared those three intervention methods in a randomized clinical study. The aim of this study is to evaluate the effect of different models of conducting medical nutrition therapy on the glycemic control in patients with type 2 diabetes.
Interventions
- BEHAVIORAL Traditional MNT
- BEHAVIORAL Structured MNT
- BEHAVIORAL Structured MNT plus Weekly Support
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2015-04 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02520050
The ClinicalTrials.gov registry entry for NCT02520050 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Traditional MNT is the first listed.
NCT02520050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02520050 about?
NCT02520050 is a clinical study titled "The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DM". The American Diabetes Association (ADA), among other medical societies, is strongly recommending medical nutrition therapy (MNT) for prevention and management of type 2 diabetes. However, the ADA recognized that there is no "one size fits all" diet and thus recommends that MNT should be conducted th...
What is the current status of trial NCT02520050?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2015-04. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02520050?
The interventions under investigation include: Traditional MNT (BEHAVIORAL), Structured MNT (BEHAVIORAL), Structured MNT plus Weekly Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT02520050?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.